Lux Health Tech Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to acquire companies in the healthcare and technology industries. The company was incorporated in 2020 and is based in New York, New York.

Lux Health Tech Acquisition Corp.

Lux Capital is a venture capital firm that makes long-term bets on contrarians and outsiders. We believe the next generation of industrialist titans will be scientists, technologists and inventors who are doing more than challenging the status quo—they’re literally challenging the laws of physics. We have offices in New York City and Menlo Park.Over the past two decades, Lux has expanded from our New York City roots to Silicon Valley, and built an over $5 billion AUM firm of more than 30 full-time professionals, with a wide spectrum of technical backgrounds and the versatility to invest at any stage, from $100,000 to $100 million.We invest in seed- and early-stage ventures across multiple sectors, including: 3D printing; machine learning; artificial intelligence; flying robots; surgical robots; synthetic biology; genomics; satellites; space; drones; computational imaging and recognition; new materials; holograms; “fixers” for the future; the internet of things; connected hardware; the smart home and virtual reality.

Zoox

Genocea Biosciences

Aeva

Aira

Auris Health

Tactic

Tempo Automation

Thrive Earlier Detection

Transphorm

CTRL-labs

Desktop Metal

Kala Pharmaceuticals

Latch

Matterport

Evolv Technology

Rigetti Computing

Science 37

Senti Biosciences

AirMap

Planet

Yonder

AltspaceVR

Shapeways

Recursion Pharmaceuticals

Resilience

Lux Capital

	Sep '20	Dec '20	Mar '21	Jun '21	Sep '21	Dec '21	Mar '22	Jun '22
revenue
cost of revenue
gross profit
selling and marketing expenses					73.90K -
general and administrative expenses		183.04K -	328.08K 79.24%	383.32K 16.84%	202.25K 47.24%	65.11K 67.81%	230.51K 254.02%	418.32K 81.47%
selling general and administrative expenses		183.04K -	328.08K 79.24%	383.32K 16.84%	276.15K 27.96%	-8.79K 103.18%	230.51K 2,722.74%	418.32K 81.47%
research and development expenses
other expenses			49.14K -	51.46K 4.73%	-73.90K 243.60%	-26.70K 63.87%
cost and expenses		183.04K -	377.22K 106.08%	434.78K 15.26%	202.25K 53.48%	-35.49K 117.55%	230.51K 749.55%	418.32K 81.47%
operating expenses		183.04K -	377.22K 106.08%	434.78K 15.26%	202.25K 53.48%	-35.49K 117.55%	230.51K 749.55%	418.32K 81.47%
interest expense						-4.90M -	-7.87M 60.57%	-5.19M 34.05%
ebitda		-244.72K -	17.58M 7,285.39%	2.01M 88.56%	2.64M 31.39%	4.86M 83.91%	7.59M 56.27%	4.72M 37.79%
operating income		-248.29K -	-377.22K 51.92%	-434.78K 15.26%	-326.57K 24.89%	-44.01K 86.52%	-279.88K 535.90%	-468.98K 67.57%
depreciation and amortization		3.57K -	17.96M 502,741.99%	2.45M 86.38%	2.97M 21.38%	4.90M 65.16%	7.87M 60.57%	5.19M 34.05%
total other income expenses net		3.57K -	17.96M 502,741.99%	2.45M 86.38%	2.97M 21.38%	4.90M 65.16%	7.87M 60.57%	5.19M 34.05%
income before tax		-244.72K -	17.58M 7,285.39%	2.01M 88.56%	2.64M 31.39%	4.86M 83.91%	7.59M 56.27%	4.72M 37.79%
income tax expense						-4.90M -	-7.87M 60.57%	34.59K 100.44%
net income		-244.72K -	17.58M 7,285.39%	2.01M 88.56%	2.64M 31.39%	9.76M 269.48%	15.47M 58.43%	4.69M 69.68%
weighted average shs out	43.13M -	43.13M 0%	43.13M 0%	12.82M 70.27%	43.13M 236.32%	43.13M 0%	43.13M 0%	34.50M 20%
weighted average shs out dil	43.13M -	43.13M 0%	43.13M 0%	43.13M 0%	43.13M 0%	43.13M 0%	43.13M 0%	34.50M 20%
eps		-0.01 -	0.41 7,292.98%	0.16 60.98%	0.06 61.69%	0.23 275.20%	0.36 56.52%	0.14 61.11%
epsdiluted		-0.01 -	0.41 7,292.98%	0.05 88.63%	0.06 31.55%	0.23 275.20%	0.36 56.52%	0.14 61.11%

NASDAQ:LUXA

Lux Capital

Last Close

10.04

28/10 20:00

Volume Today

2.48M

Avg: 203.47K

PE Ratio

17.20

PFCF: -

Preview